l carnitine atrial fibrillation l-Carnitine and heart disease Proposed mechanisms for the interaction
Description
92 : 231236 Peng H, Froehner S
2011;343:d5928
doi: 10.1002/cphy.c130024
Recalls & Warnings September 10, 2013 CoQ10 and Carnitine Supplement Company Warned For Manufacturing Violations On April 15, 2013, the FDA issued a warning letter to Irenda Corporation, following a facility inspection which found the company's products, including L-Carnitine, Acetyl L-Carnitine, and Co-Q 10 with L-Carnitine, to be adulterated because they were packed, or held under conditions that violate
